Advisory Research Inc Dexcom Inc Transaction History

Advisory Research Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $54,440 - $64,381	-570 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $79,666 - $133,887	-1,271 Reduced 69.04%	570 $231,000
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $66,762 - $105,655	-1,397 Reduced 43.14%	1,841 $496,000
Q4 2019 Feb 11, 2020	SELL	$36.62 - $57.29 $67,454 - $105,528	-1,842 Reduced 36.26%	3,238 $708,000
Q3 2019 Nov 12, 2019	BUY	$35.53 - $43.8 $70,775 - $87,249	1,992 Added 64.51%	5,080 $758,000
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $41,760 - $58,380	-1,500 Reduced 32.69%	3,088 $463,000
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $46,427 - $63,149	1,654 Added 56.37%	4,588 $546,000
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $31,038 - $42,975	-1,150 Reduced 28.16%	2,934 $351,000
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $13,963 - $21,958	598 Added 17.15%	4,084 $584,000
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $61,144 - $87,916	3,486 New	3,486 $331,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.